Trial Profile
Phase III trial of gimeracil/oteracil/tegafur (S-1) in patients with advanced hepatocellular carcinoma in Japan
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 30 May 2016
Price :
$35
*
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary)
- Indications Liver cancer
- Focus Registrational; Therapeutic Use
- Acronyms S-CUBE
- Sponsors Taiho Pharmaceutical
- 02 Jun 2015 Results presented at the 51st Annual Meeting of the American Society of Clinical Oncology.
- 08 Sep 2014 New trial record